|
VRTX | Vertex Pharmaceuticals Inc / Ma |
|
|
VRTX | Vertex Pharmaceuticals Inc / Ma |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.42 |
| Leverage | 27.42% |
| Market Cap | $ 118.6B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -998.8m |
| Margin | -9.08% |
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.